Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine

BACKGROUND: The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, Jason S., Yao, Michel K., Tran, Kaylie N., Croyle, Maria A., Strong, James E., Feldmann, Heinz, Kobinger, Gary P.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669164/
https://www.ncbi.nlm.nih.gov/pubmed/19390586
http://dx.doi.org/10.1371/journal.pone.0005308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669164/
https://www.ncbi.nlm.nih.gov/pubmed/19390586
http://dx.doi.org/10.1371/journal.pone.0005308

Ejemplares similares